5-(3-piperidino-propyl)-10,11-dihydro-5H-dibenz[b,f]azepine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: 5-(3-piperidino-propyl)-10,11-dihydro-5H-dibenz[b,f]azepine
• 英文别名: 5-(3-Piperidino-propyl)-10,11-dihydro-5H-dibenz[b,f]azepin；5-(3-Piperidinopropyl)-10,11-dihydro-5H-dibenz(b,f)azepine；11-(3-piperidin-1-ylpropyl)-5,6-dihydrobenzo[b][1]benzazepine
• 化学式: C₂₂H₂₈N₂
• 分子量: 320.478
• InChiKey: ROIVPAWMCJVZON-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.2
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  6.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  亚氨基二苄 在 sodium amide 、 苯 作用下， 生成 5-(3-piperidino-propyl)-10,11-dihydro-5H-dibenz[b,f]azepine
  参考文献：
  名称：

  关于亚氨基二苄基衍生物

  摘要：

  1.描述了亚氨基二苄基（10，11-二氢-5-二苯并-[b，f]-氮杂）的氨基烷基化和氨基酰化衍生物的制备。

  DOI：

  10.1002/hlca.19540370211

文献信息

• SMALL MOLECULE COMPOUNDS FOR STEM CELL DIFFERENTIATION
  申请人：Mercola Mark

  公开号：US20100159596A1

  公开（公告）日：2010-06-24

  Methods and small molecule compounds for stem cell differentiation are provided. One example of a class of compounds that may be used is represented by the compound having the structure IA or IB in the form of free base or a pharmaceutically acceptable salt, hydrate, solvate or N-oxide thereof: R 1 is independently hydrogen or (C 1 -C 6 )alkyl; R 2 is independently hydrogen, (C 1 -C 6 )alkyl, aryl, or heteroaryl; R 2′ is independently hydrogen, (C 1 -C 6 )alkyl, CF 3 or C 2 F 5 ; R 3 is independently (C 1 -C 6 )alkyl, aryl, 2-tetrahydrofurylmethyl, an aliphatic tertiary amine, or 4-methoxybenzyl; or R 2 and R 3 may be joined together to form a 5 or 6 member ring lactone; R 4 is independently hydrogen, (C 1 -C 6 )alkyl, a 2- or 4-R 5 -substituted aromatic ring selected from a 4-R 5 -phenyl or a 2-R 5 -5-pyridyl, aryl, heteroaryl, aliphatic tertiary amine or halogen; and R 5 , R 5′ , R 6 , R 6′ , R 7 , R 7′ , are each independently hydrogen, (C 1 -C 6 )alkyl, aryl, optionally substituted phenyl, heteroaryl, a heterocyclic ring, an aliphatic tertiary amine, or halogen.

  提供干细胞分化的方法和小分子化合物。可以使用的一类化合物的一个示例由结构IA或IB表示，以自由碱基或其药学上可接受的盐，水合物，溶剂或N-氧化物的形式存在：R1独立地是氢或（C1-C6）烷基; R2独立地是氢，（C1-C6）烷基，芳基或杂环芳基; R2'独立地是氢，（C1-C6）烷基，CF3或C2F5; R3独立地是（C1-C6）烷基，芳基，2-四氢呋喃甲基，脂肪族三级胺或4-甲氧基苄基; 或者R2和R3可以结合形成5或6元环内酯; R4独立地是氢，（C1-C6）烷基，2-或4-R5-取代的芳环，选自4-R5-苯基或2-R5-5-吡啶基，芳基，杂环芳基，脂肪族三级胺或卤素; R5，R5'，R6，R6'，R7，R7'独立地是氢，（C1-C6）烷基，芳基，可选取代的苯基，杂环芳基，杂环环，脂肪族三级胺或卤素。
• TRICYCLIC COMPOUNDS AS MELANOGENESIS MODIFIERS AND USES THEREOF
  申请人：ORLOW Seth J.

  公开号：US20090304615A1

  公开（公告）日：2009-12-10

  A method of identification of tricyclic compounds (formula I) that control melanin synthesis (melanogenesis), and the use of such compounds and compositions thereof to modify (e.g., inhibit) melanin production are disclosed. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of conditions that are causally related to aberrant melanogenesis activity including by way of non-limiting example, hyperpigmentation and others.
• US9012217B2
  申请人：——

  公开号：US9012217B2

  公开（公告）日：2015-04-21
• [EN] TRICYCLIC COMPOUNDS AS MELANOGENESIS MODIFIERS AND USES THEREOF<br/>[FR] COMPOSÉS TRICYCLIQUES EN TANT QUE MODIFICATEURS DE LA MÉLANOGENÈSE ET LEURS UTILISATIONS
  申请人：UNIV NEW YORK SCHOOL MEDICINE

  公开号：WO2009064493A1

  公开（公告）日：2009-05-22

  A method of identification of tricyclic compounds (formula I) that control melanin synthesis (melanogenesis), and the use of such compounds and compositions thereof to modify (e.g., inhibit) melanin production are disclosed. Formula (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of conditions that are causally related to aberrant melanogenesis activity including by way of non-limiting example, hyperpigmentation and others.
• Über Derivate des Iminodibenzyls
  作者：W. Schindler、F. Häfliger

  DOI：10.1002/hlca.19540370211

  日期：——

  1. Es wird die Darstellung von aminoalkylierten und aminoacylierten Derivaten des Iminodibenzyls (10, 11-Dihydro-5-dibenzo-[b, f]-azepin) beschrieben.

  1.描述了亚氨基二苄基（10，11-二氢-5-二苯并-[b，f]-氮杂）的氨基烷基化和氨基酰化衍生物的制备。